Reiko
  • Home
  • About Us
      • Back
      • Trustees
      • Our Objectives
      • Our Mission
      • Why Donate?
      • PSGR Past Trustees 
  • Contact Us
      • Back
      • Join PSGR
  • Precautionary Principle
  • Global Responsibility

  • You are here:  
  • Home
  • RECLAIMING HEALTH FAQs
  • Why is insulin resistance a more informative cardiometabolic biomarker than LDL cholesterol (LDL-C)?

Why is insulin resistance a more informative cardiometabolic biomarker than LDL cholesterol (LDL-C)?

Insulin resistance is more informative because it explains the full cardiometabolic risk pattern, including glycaemic instability, elevated triglycerides, hypertension, inflammation, and progression to type 2 diabetes. LDL-C, by contrast, measures only the cholesterol content within LDL particles and does not reliably reflect risk in isolation; individuals with identical LDL-C values can have very different particle numbers and risk profiles.

Cholesterol-centred models became dominant because cholesterol was measurable early and served as a convenient surrogate target. However, LDL particles exist to transport cholesterol for essential physiological functions, and there is no fixed cholesterol content per LDL particle. Treating LDL-C as the primary causal driver can therefore obscure upstream metabolic dysfunction, particularly insulin resistance and triglyceride dysregulation, that better explains contemporary cardiovascular disease risk.


BACK TO:
  • MAIN FAQ PAGE
  • RECLAIMING HEALTH PAGE

Information

  • NEWS NOW: RECLAIMING HEALTH
  • SCIENCE FOR PUBLIC GOOD
  • PSGR REPORTS & PAPERS
  • RESPONSES/SUBMISSIONS TO PUBLIC CONSULTATIONS
    • GENERAL GOVERNMENT
    • MINISTRY OF HEALTH (MoH)
    • MINISTRY FOR THE ENVIRONMENT (MfE)
    • MINISTRY FOR PRIMARY INDUSTRIES (MPI)
    • NZ ENVIRONMENTAL PROTECTION AUTHORITY (NZEPA)
    • FOOD STANDARDS AUSTRALIA NEW ZEALAND (FSANZ)
    • ROYAL COMMISSIONS
      • 2000 NZ Royal Commission on Genetic Modification
      • NZ Royal Commission COVID-19 Lessons Learned
    • LOCAL POLICY: TERRITORIAL & LOCAL COUNCILS (TLAs)
    • INTERNATIONAL
  • ENDOCRINE DISRUPTION
  • FLUORIDATED DRINKING WATER
  • GENETICS & EPIGENETICS
  • LINKS
  • TAKING ACTION
  • PROPAGANDA
  • REGULATORY CAPTURE
  • GENERAL CORRESPONDENCE/LETTERS
    • Letters & Emails - New Zealand
    • Ombudsman
    • New Zealand Councils

Topics

  • RECLAIMING HEALTH
  • RECLAIMING HEALTH FAQs
  • PSGR IN CONVERSATION WITH SCIENTISTS & DOCTORS
  • OUR ANNUAL UPDATE: SCIENCE, GOVERNANCE & HEALTH
  • STEWARDING: RF-EMF EMISSIONS
  • STEWARDING: CBDCS & DIGITAL ID's
  • STEWARDING: GENE EDITING TECHNOLOGY
    • SHORT CIRCUITED? GENE TECH & SCIENCE REFORM
  • STEWARDING: FRESHWATER
  • STEWARDING: ANTHROPOGENIC EMISSIONS (NOVEL ENTITIES)
  • COVID-19 / Sars-Cov-2

Providing scientific & medical information & analysis in the service of the public's right to be independently informed on issues relating to human & environmental health.

  • Contact Us
  • About Us

Who's Online

We have 58 guests online


Twitter Instagram Youtube LinkedIn Spotify Substack Bluesky

 

© Physicians and Scientists for Global Responsibility New Zealand Charitable Trust